SynthesisFrontiers in endocrinology2026
Correlations between iodine status and the risk of thyroid nodules, a systematic review and dose-response meta-analysis.
Synthesis in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Could iodine be the missing micronutrient in breast cancer development?Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The global incidence of thyroid nodules is rising substantially. The correlation between excessive iodine intake and an elevated risk of thyroid nodules remains a subject of debate. Objective: To evaluate the categorical and quantitative dose-response associations between iodine status levels and the risk of thyroid nodules. Methods: We systematically searched PubMed, Web of science, Embase, Cochrane Library and Scopus for studies published before December 2025 that investigated the association between iodine status and thyroid nodules, without language restrictions. The categorical association was assessed by pooling odds ratios (ORs) for thyroid nodules across different iodine status categories, using the adequate category as the reference. The continuous dose-response association was evaluated using random-effects generalized least squares spline models. The primary outcome was the prevalence of thyroid nodules at different iodine status statuses. Results: This meta-analysis included 25 cross-sectional studies comprising 54621 participants (57.7% women) and 13569 thyroid nodule events. In categorical analyses, participants in the iodine deficiency (median urinary iodine concentration [UIC]: 50 μg/L) showed higher odds of thyroid nodules (OR = 1.28, 95%CI=1.09-1.50) compared to the adequate iodine category (median UIC, 150 μg/L). No significant association was found for both the more-than-adequate iodine (median UIC, 250 μg/L) category and excessive iodine (median UIC, 350 μg/L) categories (OR = 1.02, 95% CI = 0.93-1.11; OR = 1.13, 95%CI=0.98-1.30, respectively). Nine studies reporting continuous UIC outcomes, the mean difference (MD) between participants with and without nodules was 4.11 (95% CI, 2.51 to 5.71, P < 0.01). Continuous dose-response analysis revealed a significant U-shaped nonlinear correlation (P for nonlinearity < 0.001), with increased risks at both deficient and excessive iodine levels. These associations remained consistent in analyses by unadjusted variables of sex, age and BMI. Further analysis stratified by geographical factors also revealed similar correlation tendency. Conclusions: The relationship between iodine intake and thyroid nodule risk follows a U-shaped, nonlinear pattern, where both deficiency and excess are associated with increased risks. More than adequate iodine intake showed a trend toward a lower prevalence of thyroid nodules. However, this observation should be interpreted with caution due to wide confidence intervals, heterogeneity, and potential residual confounding. Systematic Review Registration: PROSPERO, https://www.crd.york.ac.uk/PROSPERO/view/CRD420251236621, identifier CRD420251236621.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.